GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celestial Biolabs Ltd (BOM:532871) » Definitions » Gross-Profit-to-Asset %

Celestial Biolabs (BOM:532871) Gross-Profit-to-Asset % : 0.31% (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Celestial Biolabs Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Celestial Biolabs's annualized Gross Profit for the quarter that ended in Dec. 2023 was ₹0.53 Mil. Celestial Biolabs's average Total Assets over the quarter that ended in Dec. 2023 was ₹172.37 Mil. Therefore, Celestial Biolabs's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 0.31%.


Celestial Biolabs Gross-Profit-to-Asset % Historical Data

The historical data trend for Celestial Biolabs's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celestial Biolabs Gross-Profit-to-Asset % Chart

Celestial Biolabs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.38 2.87 - 0.34 0.36

Celestial Biolabs Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.39 0.29 0.28 0.31

Competitive Comparison of Celestial Biolabs's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Celestial Biolabs's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Celestial Biolabs's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Celestial Biolabs's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Celestial Biolabs's Gross-Profit-to-Asset % falls into.



Celestial Biolabs Gross-Profit-to-Asset % Calculation

Celestial Biolabs's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2023 )/( (Total Assets (A: Mar. 2022 )+Total Assets (A: Mar. 2023 ))/ count )
=0.626/( (171.777+172.367)/ 2 )
=0.626/172.072
=0.36 %

Celestial Biolabs's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Mar. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=0.528/( (172.367+0)/ 1 )
=0.528/172.367
=0.31 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Celestial Biolabs Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Celestial Biolabs's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Celestial Biolabs (BOM:532871) Business Description

Traded in Other Exchanges
N/A
Address
Plot No. 59, Road No 12, TSIIC Tech Park, IDA Nacharam, Hyderabad, TG, IND, 500076
Celestial Biolabs Ltd is an India based biopharmaceutical company. It is engaged in the business activity producing and supplying of the biotechnological products. The company offers herbal, feed supplement and nutraceutical products. The proprietary herbal products of the group include BIOVITA, CADALMIN GAE, CEL-DIGEST, BIOLIV, RHUMACEL, CEL-CLEAR, Trem Plus, O-KOF, BIOPOWER GOLD, BIO-DNORM, DERMACEL, GYNOCEL, HEALTHONE, RELIFIN, and C-KAPS. The organization formulates and manufactures Ayurvedic proprietary products for the Indian market.

Celestial Biolabs (BOM:532871) Headlines

No Headlines